NCT06470464 2025-09-18Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac TumorShandong First Medical UniversityPhase 2 Completed20 enrolled
NCT03989336 2024-07-15A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian CancerChinese PLA General HospitalPhase 2 Completed84 enrolled
NCT01478685 2019-11-12A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCelgenePhase 1 Completed169 enrolled